
© Juan Carlos Tomasi
Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.
Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

In a landmark case, the Indian Patent Office has issued the first-ever compulsory licence in India to a generic drug manufacturer ending pharmaceutical company Bayer’s monopoly in India on a drug used to treat kidney and liver cancer.
India 2008 © Jean-Marc Giboux/Getty Images

© Juan Carlos Tomasi
Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.
UN Rapporteur supports MSF's "Hands Off" Campaign
UN Special Rapporteur on the Right to Health Anand Grover describes just how critical India's role in providing generic medicines to developing countries around the world...

© Julie Remy
MSF created the Access Campaign to help get our patients the best possible treatment which includes looking at the political and commercial barriers that stand in the way of access to affordable medicine.
26 million children – roughly one in five born each year – remained un-immunised globally